A toxic combination of cash burn and equity dilution could leave a hole in your investment portfolio.Penny stocks are shares in companies that trade for less than $5.00 per share. With a current price of $6.67,AMC Entertainment isn't far from that mark. And while the stock might look like a good deal, it is cheap for a reason. Let's explore why the struggling movie theater operator looks poised for more downside over the long term.Profitability challenges and weird managerial decisionsWe all know the COVID-19 pandemic devastated in-person entertainment venues like movie theaters, which saw their locations closed for much of 2020 and 2021. Now that the industry is back on its feet, sales are soaring -- but profitability has been slower to return. AMC's third-quarter earnings repor
Microsoft is pulling back to correct the October 2021 cycle low, we like to look for the blue boxes in 3, 7 or 11 swing where buyers can enter for a bounce. Further downside is still favoured to take place at this point, but we don’t like to sell it, only buy in 3, 7 or 11 at the blue boxes.$Microsoft(MSFT)$
In 2021, the number of game users in China has maintained steady growth, with the number of users reaching 666 million, a year-on-year increase of 0.22%.Compared with 2020, the growth rate of this year has little change in user scale, and the dividend of the gaming population tends to be saturated. In addition, the user scale in the second half of the year has shown a downward trend compared with the first half of the year. As the leader of China's game industry, Tencent will definitely get better and better while the game industry is booming. Go long!$TENCENT(00700)$
Watch out the fourth week is treacherous for direct listings / failed de-SPACs Failed meaning = failed to hold $10 I am ling anybody have any insight as to when this will get over $8 so I can get called away? I keep selling the $8 strike calls$Grab Holdings(GRAB)$
any new opinions on BEKE ????- looks like it has bottomed below $20 as it is up about 15% since then. This is nothing in light of the over 70% drop, but without the regulations this stock should fly as it is the kingpin of the real estate market in China. Evergrande or not, this company will succeed.$KE Holdings Inc.(BEKE)$$Evergrande Property Services Group Limited(EVGPF)$
The idea that stopping to print money and raising nominal interest rates at 0.75% is bad for stock is crazy. Inflation is double digit. People are getting paid, in real terms, to borrow money. This is the most accommodative monetary policy in history. Buy stocks in real businesses (eg Msft) and real estate because dollars are being depreciated.$Microsoft(MSFT)$
Have you guys ever used Grab? If you consider this company just as a ride-hailing service, it's a big mistake. Grab is a company with kinds of services. $Grab Holdings(GRAB)$
Hyundai Heavy Industries Holdings unloaded some of its stakes in Hyundai Oilbank to Palantir Technologies. The amount of stock sold to the U.S. company was valued at about $20 million. Collaborating with Palantir will be a great opportunity to strengthen Hyundai Oilbank's digital capabilities. happy investing is buying good companies and holding them. $Hyundai Heavy Industries Co., Ltd.(HYHZF)$$Palantir Technologies Inc.(PLTR)$
The patent is being accelerated since it is a biomedical device and when patents are accelerated what would take years is done around 6 months. And so anyone looking for news may be waiting until around March of 2022... that's when the Art device will hit 6 months since patent submission. I think this can profoundly raise the share price above 10 as it then begins its one year journey for FDA approval as it will probably be fast tracked through if all goes well. (I dont see any reason to not fast track through the FDA unless it makes people extremely ill, terrible side effects, or causes death and that is where the risk of an investment will be). Anyway... the only reason right now this will stay around 4 - 10 dollars is risk of FDA denial as I think the patent will go through without much
hopefully NVAX gets approval and eventually dominates the vaccine landscape. BUT make no mistake, there is no "as early as". This late. Very late. Please can even the most ardent bulls keep it objective. As it stands it's 100% pump, with no caveat, no reality check.$Novavax(NVAX)$